Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Evaluate the immune-related eRNA models and signature score to predict the response to immunotherapy in thyroid carcinoma

Fig. 6

Validation the risk signature in total cohort. A–C The risk score distribution, survival status, expression heatmap of nine immune-related eRNAs between high- and low-risk groups in total cohort. D Kaplan–Meier survival curve analysis for high- and low-risk groups. E Time-dependent ROC curve analysis of the risk signature. F PCA analysis of high- and low-risk groups in total set

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us